sacituzumab govitecan
gilead sciences
['bcsm', 'tropics-02']
 now presenting results from tropics-02. results: 5.5 mo in sacituzumab arm versus 4 mo in chemo arm with hr 0.66. #asco22 #bcsm 
Breast & gyn med onc @valleyhospital in NJ. Focus on survivorship and ?????? onc. All opinions my own. Retweets not endorsements. Host of INTERLUDE podcast ??